⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3063257 | 0.79 | — | — | |
| SCHEMBL14321155 | 0.75 | RAB9A (0.31) | — | |
| SCHEMBL4310713 | 0.75 | KMT2A (0.46) | — | |
| SCHEMBL6126305 | 0.70 | — | — | |
| SCHEMBL159035 | 0.69 | — | — | |
| SCHEMBL10378521 | 0.69 | NAPRT (0.39) | — | |
| SCHEMBL381885 | 0.67 | — | — | |
| SCHEMBL17260869 | 0.67 | — | — | |
| SCHEMBL12934318 | 0.67 | LMNA (0.43) | — | |
| SCHEMBL11443521 | 0.67 | POLB (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110265195-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2011-10-27 | — | — | US | disclosed |
| US-7932066-B2 | Unique associated kaposi's sarcoma virus sequences and uses thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2011-04-26 | — | — | US | disclosed |
| US-20090022748-A1 | Unique associated Kaposi's sarcoma virus sequences and uses thereof | CHANG YUAN | 2009-01-22 | — | — | US | disclosed |
| US-6500663-B1 | TREATING A SUBJECT AFFLICTED WITH A KAPOSI'S SARCOMA CAUSED BY KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS WHICH COMPRISES ADMINISTERING A NUCLEOSIDE ANALOG OR AN ANTISENSE NUCLEIC ACID | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2002-12-31 | — | — | US | disclosed |
| US-6348586-B1 | NUCLEOTIDE SEQUENCE OF HERPES VIRUS; DIAGNOSIS; VACCINES; VIRICIDES; ANTISENSE AGENTS; TRIPLEX OLIGONUCLEOTIDES; | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2002-02-19 | — | — | US | disclosed |
| US-6183751-B1 | VACCINES; DIAGNOSIS; OPEN READING FRAME; GENETIC ENGINEERING | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2001-02-06 | — | — | US | disclosed |
| US-6150093-A | NUCLEOTIDE SEQUENCES PREFERENTIAL FOR HERPES VIRUS ASSOCIATED WITH A CANCER; FOR TREATMENT, DIAGNOSIS AND DETECTION OF AQUIRED IMMUNODEFICIENCY SYNDROME RELATED CANCER | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2000-11-21 | — | — | US | disclosed |
| US-6093550-A | DIAGNOSING KAPOSI'S SARCOMA(KS) ASSOCIATED HERPESVIRUS INFECTION BY CONTACTING A SAMPLE WITH A KS ASSOCIATED HERPESVIRUS ANTIGEN, DETERMINING THE LEVEL OF KS ASSOCIATED HERPESVIRUS ANTIBODY BOUND TO THE ANTIGEN; IMMUNOASSAY KITS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2000-07-25 | — | — | US | disclosed |
| EP-0934333-A4 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | UNIV COLUMBIA (US) | 1999-11-03 | — | — | EP | disclosed |
| EP-0804547-A4 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | UNIV COLUMBIA (US) | 1999-11-03 | — | — | EP | disclosed |
| WO-1997027208-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1997-07-31 | — | — | WO | disclosed |
| EP-0726708-A1 | VIRUS ASSOCIATED MULTIPLE SCLEROSIS: TREATMENTS, PREVENTION AND DIAGNOSIS THEREOF | PATHOGENESIS CORPORATION (US) | 1996-08-21 | — | — | EP | disclosed |
| WO-1996015779-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1996-05-30 | — | — | WO | disclosed |
| WO-1996006159-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1996-02-29 | — | — | WO | disclosed |
| WO-1995012313-A1 | VIRUS ASSOCIATED MULTIPLE SCLEROSIS: TREATMENTS, PREVENTION AND DIAGNOSIS THEREOF | PATHOGENESIS CORPORATION (US) | 1995-05-11 | — | — | WO | disclosed |
| US-4056674-A | VIRICIDE, BACTERICIDE | ICN PHARMACEUTICALS, INC. (US) | 1977-11-01 | — | — | US | disclosed |
| US-3991078-A | VIRICIDES | ICN PHARMACEUTICALS, INC. (US) | 1976-11-09 | — | — | US | disclosed |
| US-3976545-A | WITH NUCLEOSIDE PHOSPHORYLASE AND RIBOSE-1-PHOSPHATE TO FORM 1-B-D-RIBOFURANOSYL | ICN PHARMACEUTICALS, INC. (US) | 1976-08-24 | — | — | US | disclosed |
| US-3976545-A | WITH NUCLEOSIDE PHOSPHORYLASE AND RIBOSE-1-PHOSPHATE TO FORM 1-B-D-RIBOFURANOSYL | ICN PHARMACEUTICALS, INC. (US) | 1976-08-24 | — | — | US | disclosed |
| US-3927216-A | 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections | VIRATEK, INC., A CORP. OF DE. | 1975-12-16 | — | — | US | disclosed |